Erythropoietin attenuates inflammatory factors and cell death in neonatal rats with intracerebral hemorrhage

Acta Neurochirurgica, Supplementum

Volumn , Issue 111, 2011, Pages 299-305

  Chau, Monica ^a   Chen, Dongdong ^a   Wei, Ling ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammatory factors; Interleukins; Intracerebral hemorrhage; Neuroprotection; Recombinant human erythropoietin; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NEUROPROTECTIVE AGENT; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BASAL GANGLION; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN HEMORRHAGE; CELL DEATH; CONFERENCE PAPER; CONTROLLED STUDY; ENCEPHALITIS; NEUROPROTECTION; NEWBORN; NICK END LABELING; NONHUMAN; PERINATAL PERIOD; RAT; REAL TIME POLYMERASE CHAIN REACTION; ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; CELL DEATH; CEREBRAL HEMORRHAGE; CYTOKINES; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; GENE EXPRESSION REGULATION; IN SITU NICK-END LABELING; INFLAMMATION; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 79960667780     PISSN: 00651419     EISSN: 00016268     Source Type: Book Series    
DOI: 10.1007/978-3-7091-0693-8_50     Document Type: Conference Paper

References (50)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J (2010) Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121:948-954. doi:121/7/948 [pii] 10.1161/CIRCULATIONAHA.109.192666
2. Broderick J, Talbot GT, Prenger E, Leach A, Brott T (1993) Stroke in children within a major metropolitan area: the surprising impor¬tance of intracerebral hemorrhage. J Child Neurol 8:250-255 (Pubitemid 23215715)
3. Fullerton HJ, Wu YW, Zhao S, Johnston SC (2003) Risk of stroke in children: ethnic and gender disparities. Neurology 61:189-194 (Pubitemid 36875299)
4. Sofronas M, Ichord RN, Fullerton HJ, Lynch JK, Massicotte MP, Willan AR, deVeber G (2006) Pediatric stroke initiatives and preliminary studies: what is known and what is needed? Pediatr Neurol 34:439-445. doi:S0887-8994(05)00636-3 [pii] 10.1016/j. pediatrneurol.2005.10.016 (Pubitemid 43831575)
5. Lynch JK, Hirtz DG, DeVeber G, Nelson KB (2002) Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics 109:116-123 (Pubitemid 34049435)
6. Zakhary MM, Wesolowski JR, Sewick AE, Carlson M, Mehrotha N, Maly P, Sundgren PC (2009) Prevalence and etiology of intrac-ranial hemorrhage in term children under the age of two years: a retrospective study of computerized tomographic imaging and clin¬ical outcome in 798 children. Acad Radiol 16:572-577. doi:S1076-6332(09)00035-X [pii] 10.1016/j.acra.2009.01.007
7. Schoenberg BS, Mellinger JF, Schoenberg DG (1978) Cerebro-vascular disease in infants and children: a study of incidence, clini¬cal features, and survival. Neurology 28:763-768 (Pubitemid 8382976)
8. Lanthier S, Carmant L, David M, Larbrisseau A, de Veber G (2000) Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology 54:371-378 (Pubitemid 30078068)
9. Meyer-Heim AD, Boltshauser E (2003) Spontaneous intracranial haemorrhage in children: aetiology, presentation and outcome. Brain Dev 25:416-421. doi:S0387760403000299 [pii] (Pubitemid 36945427)
10. Lipton P (1999) Ischemic cell death in brain neurons. Physiol Rev 79:1431-1568 (Pubitemid 29473320)
11. Liu XB, Wang JA, Yu SP, Keogh CL, Wei L (2008) Therapeutic strategy of erythropoietin in neurological disorders. CNS Neurol Disord Drug Targets 7:227-234
12. Chong ZZ, Kang JQ, Maiese K (2003) Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, bad, and caspase-mediated pathways. Br J Pharmacol 138:1107-1118. doi:10.1038/Sj.Bjp. 705161 (Pubitemid 36459833)
13. Youle RJ, Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9:47-59. doi:nrm2308 [pii] 10.1038/nrm2308
14. Chong ZZ, Lin SH, Kang JQ, Maiese K (2003) Erythropoietin pre¬vents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8. J Neurosci Res 71:659-669. doi:10.1002/jnr.10528 (Pubitemid 36255350)
15. Kennedy SG, Kandel ES, Cross TK, Hay N (1999) Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol Cell Biol 19:5800-5810 (Pubitemid 29339934)
16. Li Y, Ogle ME, Wallace GCt, Lu ZY, Yu SP, Wei L (2008) Erythropoietin attenuates intracerebral hemorrhage by diminishing matrix metalloproteinases and maintaining blood-brain barrier integrity in mice. Acta Neurochir Suppl 105:105-112
17. Lee ST, Chu K, Sinn DI, Jung KH, Kim EH, Kim SJ, Kim JM, Ko S Y, Kim M, Roh JK (2006) Erythropoietin reduces perihemato-mal infammation and cell death with eNOS and STAT3 activa¬tions in experimental intracerebral hemorrhage. J Neurochem 96: 1728-1739. doi:10.1111/J.1471-4159.2006.03697.X (Pubitemid 43351630)
18. Grasso G, Graziano F, Sfacteria A, Carletti F, Meli F, Maugeri R, Passalacqua M, Certo F, Fazio M, Buemi M, Iacopino DG (2009) Neuroprotective effect of erythropoietin and darbepoetin alfa after experimental intracerebral hemorrhage. Neurosurgery 65:763-769. doi:10.1227/01.NEU.0000347475.73347.5F; discussion 769-770
19. Gonzalez FF, Abel R, Almli CR, Mu D, Wendland M, Ferriero DM (2009) Erythropoietin sustains cognitive function and brain volume after neonatal stroke. Dev Neurosci 31:403-411. doi:000232558 [pii] 10.1159/000232558
20. Kim SS, Lee KH, Sung DK, Shim JW, Kim MJ, Jeon GW, Chang YS, Park WS (2008) Erythropoietin attenuates brain injury, subven-tricular zone expansion, and sensorimotor defcits in hypoxic-ischemic neonatal rats. J Korean Med Sci 23:484-491. doi:200806484 [pii] 10.3346/jkms.2008.23.3.484
21. Wei L, Han BH, Li Y, Keogh CL, Holtzman DM, Yu SP (2006) Cell death mechanism and protective effect of erythropoietin after focal ischemia in the whisker-barrel cortex of neonatal rats. J Pharmacol Exp Ther 317:109-116. doi:jpet.105.094391 [pii] 10.1124/jpet. 105.094391
22. Li Y, Lu Z, Keogh CL, Yu SP, Wei L (2007) Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood fow restoration after focal ischemia in mice. J Cereb Blood Flow Metab 27:1043-1054. doi:9600417 [pii] 10.1038/sj.jcbfm.9600417 (Pubitemid 46659037)
23. Keogh CL, Yu SP, Wei L (2007) The effect of recombinant human erythropoietin on neurovasculature repair after focal ischemic stroke in neonatal rats. J Pharmacol Exp Ther 322:521-528. doi:jpet.107.121392 [pii] 10.1124/jpet.107.121392 (Pubitemid 47105803)
24. Deng XL, Lau CP, Lai K, Cheung KF, Lau GK, Li GR (2007) Cell cycle-dependent expression of potassium channels and cell prolif¬eration in rat mesenchymal stem cells from bone marrow. Cell Prolif 40:656-670 (Pubitemid 47416548)
25. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 97:10526-10531. doi:97/19/10526 [pii]
26. Brines M (2002) What evidence supports use of erythropoietin as a novel neurotherapeutic? Oncology (Williston Park) 16:79-89
27. Arai K, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T (1990) Cytokines:coordinators of immune and infammatory responses. Annu Rev Biochem 59:783-836
28. Pregi N, Wenker S, Vittori D, Leiros CP, Nesse A (2009) TNF-alpha-induced apoptosis is prevented by erythropoietin treatment on SH-SY5Y cells. Exp Cell Res 315:419-431. doi:10.1016/J. Yexcr.2008.11.005
29. Sun Y, Calvert JW, Zhang JH (2005) Neonatal hypoxia/ischemia is associated with decreased infammatory mediators after erythro-poietin administration. Stroke 36:1672-1678. doi:10.1161/01.Str. 0000173406.04891.8c (Pubitemid 41098760)
30. Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, Viviani B, Marinovich M, Cerami A, Coleman TR, Brines M, Ghezzi P (2003) Erythropoietin selectively attenuates cytokine production and infammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 198:971-975. doi:10.1084/Jem. 20021067 (Pubitemid 37152934)
31. Turrin NP, Plata-Salaman CR (2000) Cytokine-cytokine interactions and the brain. Brain Res Bull 51:3-9. doi:S0361-9230(99)00203-8 [pii] (Pubitemid 30029062)
32. Dinarello CA (1987) The biology of interleukin-1 and comparison to tumor necrosis factor. Immunol Lett 16:227-331
33. Minami M, Kuraishi Y, Yabuuchi K, Yamazaki A, Satoh M (1992) Induction of interleukin-1 beta mRNA in rat-brain after transient forebrain ischemia. J Neurochem 58:390-392
34. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K (1995) Interleukin-1 as a pathogenetic mediator of ischemic brain-damage in rats. Stroke 26:676-680
35. Giulian D, Lachman LB (1985) Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 228:497-499 (Pubitemid 15109103)
36. Masada T, Hua Y, Xi G, Yang GY, Hoff JT, Keep RF (2001) Attenuation of intracerebral hemorrhage and thrombin-induced brain edema by overexpression of interleukin-1 receptor antagonist. J Neurosurg 95:680-686. doi:10.3171/jns.2001. 95.4.0680 (Pubitemid 33031430)
37. Gordon CR, Merchant RS, Marmarou A, Rice CD, Marsh JT, Young HF (1990) Effect of murine recombinant interleukin-1 on brain oedema in the rat. Acta Neurochir Suppl (Wien) 51:268-270
38. Megyeri P, Abraham CS, Temesvari P, Kovacs J, Vas T, Speer CP (1992) Recombinant human tumor necrosis factor alpha constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets. Neurosci Lett 148:137-140 (Pubitemid 23007723)
39. Holmin S, Mathiesen T (2000) Intracerebral administration of interleukin-1beta and induction of infammation, apoptosis, and vaso genic edema. J Neurosurg 92:108-120. doi:10.3171/jns.2000. 92.1.0108 (Pubitemid 30022094)
40. Castillo J, Davalos A, Alvarez-Sabin J, Pumar JM, Leira R, Silva Y, Montaner J, Kase CS (2002) Molecular signatures of brain injury after intracerebral hemorrhage. Neurology 58:624-629 (Pubitemid 34164947)
41. Hua Y, Wu J, Keep RF, Nakamura T, Hoff JT, Xi G (2006) Tumor necrosis factor-alpha increases in the brain after intracerebral hemorrhage and thrombin stimulation. Neurosurgery 58:542-550. doi:10.1227/01.NEU.0000197333.55473.AD 00006123-200603000-00017 [pii]; discussion 542-550
42. Nawashiro H, Tasaki K, Ruetzler CA, Hallenbeck JM (1997) TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J Cereb Blood Flow Metab 17:483-490. doi:10.1097/00004647-199705000-00001 (Pubitemid 27250974)
43. Figiel I (2008) Pro-infammatory cytokine TNF-alpha as a neuro-protective agent in the brain. Acta Neurobiol Exp (Wars) 68: 526-534. doi:6855 [pii]
44. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ (1997) Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28:1233-1244 (Pubitemid 27248902)
45. Meistrell ME, Botchkina GI, Wang HC, DiSanto E, Cockroft KM, Bloom O, Vishnubhakat JM, Ghezzi P, Tracey KJ (1997) Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia. Shock 8:341-348 (Pubitemid 127654347)
46. Pettigrew LC, Kindy MS, Scheff S, Springer JE, Kryscio RJ, Li Y, Grass DS (2008) Focal cerebral ischemia in the TNFalpha-transgenic rat. J Neuroinfammation 5:47. doi:1742-2094-5-47 [pii] 10.1186/1742-2094-5-47
47. Tseng MY, Hutchinson PJ, Richards HK, Czosnyka M, Pickard JD, Erber WN, Brown S, Kirkpatrick PJ (2009) Acute systemic erythropoietin therapy to reduce delayed ischemic defcits follow¬ing aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article. J Neurosurg 111:171-180. doi:10.3171/2009.3.JNS081332
48. Tseng M Y, Hutchinson PJ, Kirkpatrick PJ (2010) Interaction of neurovascular protection of erythropoietin with age, sepsis, and sta¬tin therapy following aneurysmal subarachnoid hemorrhage. J Neurosurg 112:1235-1239. doi:10.3171/2009.10.Jns09954
49. Tseng MY, Richards H, Czosnyka M, Pickard JD, Kirkpatrick PJ (2007) Acute systemic erythropoietin therapy reduces cerebral vasospasin and delayed ischemic defcits after aneurysmal subarachnoid hemorrhage: a phase II randomized, double-blind, placebo-controlled trial. J Neurosurg 106:A768
50. Tseng MY, Hutchinson PJ, Richards HK, Czosnvka M, Pickard JD, Erber WN, Brown S, Kirkpatrick PJ (2009) Acute systemicerythropoietin therapy to reduce delayed ischemic defcits follow¬ing aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. J Neurosurg 111:171-180. doi:10.3171/2009.3.Jns081332